Is ALT or ALZN more undervalued in 2026?

CirclFi compares Altimmune, Inc. (ALT) and Alzamend Neuro, Inc. (ALZN) using 13 institutional-grade valuation models. ALT has a Quality of Company score of 4.7/10 while ALZN scores 4.1/10.

Which is a better buy — ALT or ALZN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ALT and ALZN valuations compare?

ALT at $3.05 and ALZN at $1.19 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ALT vs ALZN Valuation Comparison 2026 — Intrinsic Value Analysis

ALT

Biotechnology

Altimmune, Inc.

Quality

4.7

out of 10

Value Trap

WARN

Price

$3.05

Last close

Models

9/13

Active

ALZN

Biotechnology

Alzamend Neuro, Inc.

Quality

4.1

out of 10

Value Trap

SAFE

Price

$1.19

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ALT Fair Value	ALT Upside	ALZN Fair Value	ALZN Upside
Bayesian DCF	Intrinsic	$1.01	-67.0%	$0.71	-40.4%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.10	-96.4%	$0.05	-95.4%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ALT vs ALZN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ALT vs ALZN — Which Stock Is More Undervalued?

ALT scores higher with a 4.7/10 quality rating vs ALZN's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Altimmune, Inc. (ALT) and Alzamend Neuro, Inc. (ALZN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ALT currently trades at $3.05 with a QOC of 4.7/10, while ALZN trades at $1.19 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).